Viewing Study NCT00496132


Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2026-01-07 @ 10:37 AM
Study NCT ID: NCT00496132
Status: TERMINATED
Last Update Posted: 2017-07-02
First Post: 2007-07-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Sponsor: Genentech, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ACO4198g
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators